IL189681A0 - Sustained-release preparation - Google Patents
Sustained-release preparationInfo
- Publication number
- IL189681A0 IL189681A0 IL189681A IL18968108A IL189681A0 IL 189681 A0 IL189681 A0 IL 189681A0 IL 189681 A IL189681 A IL 189681A IL 18968108 A IL18968108 A IL 18968108A IL 189681 A0 IL189681 A0 IL 189681A0
- Authority
- IL
- Israel
- Prior art keywords
- sustained
- release preparation
- release
- preparation
- Prior art date
Links
- 239000003405 delayed action preparation Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005241776 | 2005-08-23 | ||
| PCT/JP2006/316181 WO2007023729A1 (ja) | 2005-08-23 | 2006-08-17 | 徐放性製剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL189681A0 true IL189681A0 (en) | 2008-06-05 |
Family
ID=37771477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL189681A IL189681A0 (en) | 2005-08-23 | 2008-02-21 | Sustained-release preparation |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20090117190A1 (pt) |
| EP (1) | EP1927358A4 (pt) |
| JP (1) | JPWO2007023729A1 (pt) |
| KR (1) | KR20080055797A (pt) |
| CN (1) | CN101277699B (pt) |
| AU (1) | AU2006282506A1 (pt) |
| BR (1) | BRPI0614949A2 (pt) |
| CA (1) | CA2620259A1 (pt) |
| IL (1) | IL189681A0 (pt) |
| TW (1) | TW200800207A (pt) |
| WO (1) | WO2007023729A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8912192B2 (en) | 2010-02-12 | 2014-12-16 | Taisho Pharmaceutical Co., Ltd | Extended release preparation |
| US9446000B2 (en) * | 2011-09-08 | 2016-09-20 | Masdar Institute Of Science And Technology | Cellulosic gel material as a pharmaceutical excipient |
| CN110251475B (zh) * | 2019-07-25 | 2021-07-16 | 沈阳信康药物研究有限公司 | 一种帕利哌酮片剂及其制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4680323A (en) * | 1983-12-01 | 1987-07-14 | Hans Lowey | Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration |
| JPH0759521B2 (ja) * | 1985-09-30 | 1995-06-28 | 藤沢薬品工業株式会社 | ゲル層形成型徐放性製剤 |
| US4798725A (en) * | 1986-06-16 | 1989-01-17 | Norwich Eaton Pharmaceuticals, Inc. | Sustained release capsule |
| JP3140465B2 (ja) * | 1992-09-18 | 2001-03-05 | 山之内製薬株式会社 | ハイドロゲル徐放性製剤 |
| JP3598049B2 (ja) * | 1992-09-18 | 2004-12-08 | 山之内製薬株式会社 | ハイドロゲル徐放性製剤 |
| JP4292588B2 (ja) * | 1997-01-31 | 2009-07-08 | 日産化学工業株式会社 | ピリダジノン化合物類の経口製剤 |
| TW482675B (en) * | 1997-01-31 | 2002-04-11 | Green Cross Corp | Compositions for oral administration containing pyridazinone compounds technical field of the invention |
| US6403597B1 (en) * | 1997-10-28 | 2002-06-11 | Vivus, Inc. | Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation |
| EP1043031A4 (en) * | 1997-12-26 | 2007-05-02 | Astellas Pharma Inc | MEDICINAL COMPOSITIONS WITH PROLONGED RELEASE |
| US6387383B1 (en) * | 2000-08-03 | 2002-05-14 | Dow Pharmaceutical Sciences | Topical low-viscosity gel composition |
| JP2002068964A (ja) * | 2000-08-24 | 2002-03-08 | Nichiko Pharmaceutical Co Ltd | 経口用徐放錠 |
-
2006
- 2006-08-17 BR BRPI0614949-9A patent/BRPI0614949A2/pt not_active IP Right Cessation
- 2006-08-17 CA CA002620259A patent/CA2620259A1/en not_active Abandoned
- 2006-08-17 US US12/064,393 patent/US20090117190A1/en not_active Abandoned
- 2006-08-17 AU AU2006282506A patent/AU2006282506A1/en not_active Abandoned
- 2006-08-17 KR KR1020087003926A patent/KR20080055797A/ko not_active Ceased
- 2006-08-17 JP JP2007532080A patent/JPWO2007023729A1/ja active Pending
- 2006-08-17 WO PCT/JP2006/316181 patent/WO2007023729A1/ja not_active Ceased
- 2006-08-17 EP EP06782794A patent/EP1927358A4/en not_active Withdrawn
- 2006-08-17 CN CN2006800309964A patent/CN101277699B/zh not_active Expired - Fee Related
- 2006-08-23 TW TW095130999A patent/TW200800207A/zh unknown
-
2008
- 2008-02-21 IL IL189681A patent/IL189681A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1125289A1 (en) | 2009-08-07 |
| BRPI0614949A2 (pt) | 2011-04-26 |
| US20090117190A1 (en) | 2009-05-07 |
| KR20080055797A (ko) | 2008-06-19 |
| JPWO2007023729A1 (ja) | 2009-02-26 |
| CN101277699B (zh) | 2011-01-12 |
| WO2007023729A1 (ja) | 2007-03-01 |
| TW200800207A (en) | 2008-01-01 |
| EP1927358A1 (en) | 2008-06-04 |
| EP1927358A4 (en) | 2010-10-13 |
| CA2620259A1 (en) | 2007-03-01 |
| AU2006282506A1 (en) | 2007-03-01 |
| CN101277699A (zh) | 2008-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL191774A0 (en) | Solid preparation | |
| DE602006018627D1 (en) | Cholesterol-absorptionsinhibitor | |
| DE602006013270D1 (en) | Prrs-impfstoffe | |
| IL187919A0 (en) | 4c | |
| DE602006017073D1 (en) | Aspartylproteasehemmer | |
| AP2108A (en) | Novel biphenylsulfonamides | |
| DK1866498T3 (en) | C-profil | |
| DE602006003064D1 (en) | Tripeptid- und tetrapeptid-thioether | |
| DE602006009492D1 (en) | Fluidmaschinen | |
| DE602006009835D1 (en) | Nthalten | |
| DE602006016951D1 (en) | 2-cyanoacrylatzusammensetzung | |
| DE602006014261D1 (en) | Benzimidazolverbindungen | |
| DE502005007477D1 (en) | Delta-sigma-modulator | |
| IL190616A0 (en) | Novel selection system | |
| ZA200801986B (en) | Standard | |
| IL189681A0 (en) | Sustained-release preparation | |
| DE602006015303D1 (en) | Lecknachweisflicken | |
| DE502006004337D1 (en) | Strangführungsrolle | |
| DE502006007734D1 (en) | Thiazolcarbonsäureanilide | |
| AU3237P (en) | Balcabpink Calibrachoa | |
| PL367010A1 (en) | Anti-recession preparation | |
| AU3292P (en) | DP303 Dianella prunina | |
| AU3401P (en) | Archise Arctotis fastuosa | |
| AU3621P (en) | Scacover Scaevola aemula | |
| AU4036P (en) | Dottie Calathea roseo-picta |